brexucabtagene autoleucel
gilead sciences
['car t', 'mantle,(-dismantle)', 'lymphoma', 'zuma-2']
the #noeticinsight team has all the latest from #asco22 - 3 years worth of follow-up data from zuma-2 shows that car t-cell therapy kte-x19 has a lasting effect in r/r mantle cell lymphoma, is safe overall, &amp; carries low risk of late relapse. 